DAC Beachcroft Advises Biopharma On £3.5M Share Sale
Poolbeg Pharma PLC said Tuesday it has conditionally raised £3.5 million ($4.7 million) through a share sale to fund two clinical trials through to completion and boost its position in talks...To view the full article, register now.
Already a subscriber? Click here to view full article